Gleave, Martin,Signaevsky, Maxim,Jansen, Burkhard,Beraldi, Eliana,Trougakos, Ioannis P,Gonos, Efstatjios S
申请号：
NO20121038
公开号：
NO337130B1
申请日:
2012.09.14
申请国别(地区):
NO
年份:
2016
代理人:
摘要：
RNAi sequences that are useful as therapeutics in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma and Alzheimers disease. These sequences target clusterin, IGFBP-5, IGFBP-2, both IGFBP-2 and -5 simultaneously, Mitf, and B-raf. The invention further provides for the use of these RNAi sequences in the treatment of cancers of various types, including prostate cancer, sarcomas such as osteosarcoma, renal cell carcinoma, breast cancer, bladder cancer, lung cancer, colon cancer, ovarian cancer, anaplastic large cell lymphoma and melanoma and Alzheimers disease, and a method of treating such conditions through the administration of the RNA molecules with RNAi activity to an individual, including a human individual in need of such treatment.
